恆康醫療(002219.SZ):擬清算產業併購基金京福華越
格隆匯1月16日丨恆康醫療(002219.SZ)公佈,因醫療服務行業的特殊性,可能存在醫院改制、土地變性等不確定性,為降低公司併購風險,公司於2016年12月20日召開第四屆董事會第二十二次會議,審議通過了《關於參與投資產業併購基金的議案》,同意公司用自有資金5920.00萬元作為劣後級有限合夥人參與投資京福華越(台州)資產管理中心(有限合夥)(“京福華越”或“產業併購基金”),投資退出期36個月。
根據合夥協議投資退出期已到,近日公司收到京福華越執行事務合夥人京福資產管理有限公司(“京福資產”)發出的《關於成立京福華越(台州)資產管理中心(有限合夥)清算小組的通知》的書面通知,因產業併購基金投資退出期已屆滿,京福資產決定成立清算組並進入依法解散清算程序。
根據合夥協議約定,京福華越清算後可能對公司產生如下影響或風險:
1、京福華越的經營虧損由有限合夥財產彌補,在有限合夥出現虧損時公司作為劣後級有限合夥人排在第一順位按實繳出資額承擔虧損。
2、京福華越清算時,如優先級有限合夥人和中間級有限合夥人累計獲得分配的金額不足京福華越清算時優先級有限合夥人和中間級有限合夥人的全部最高參考收益(共計約730萬元)及實繳出資額之和時,公司或者指定的第三方應收購優先級有限合夥人和中間級有限合夥人持有的全部合夥權益。
3、若公司在未履行相關收購義務的情形下,優先級有限合夥人和/或中間級有限合夥人有權向任一第三方轉讓其持有的全部或部分合夥權益。如優先級有限合夥人和/或中間級有限合夥人根據合夥協議約定將其持有的合夥權益全部轉讓給第三方且第三方向優先級有限合夥人和/或中間級有限合夥人支付的收購價款低於合夥協議約定的收購價款金額的,則公司或其指定第三方應對該差額部分予以補足。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.